Change in number of shares in Brighter AB.

Conversion of convertible notes into shares under the Convertible Notes issued under the financing agreement announced on April 26.

The number of Notes converted on October 11, 2017 was 10. The number of Notes remaining under the second Tranche for future conversion is 3. The number of shares and the number of votes before the conversion was 62,410,093. Through the conversion, the number of shares and the number of votes have increased by 120,722. The total number of shares and the total number of votes after the conversion amount to 62,530,865.

For terms and conditions of the Notes, please visit: http://brighter.se/en/investors/documents/

For more information, please contact:

Truls Sjöstedt, CEO      
Tel: +46 709 73 46 00      
Email: truls.sjostedt@brighter.se

Henrik Norström, COO      
Tel: +46 733 40 30 45      
Email: henrik.norstrom@brighter.se

About Brighter AB (publ)      
Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and its first launch Actiste®, the company creates a more efficient care chain with focus on the individual. The goal is to simplify, streamline and enhance the information flow of relevant and reliable data between the patient and health care professionals. Brighter is initially focused on diabetes care, but there are opportunities in the future to operate on a broader level, spanning more diseases and treatment approaches. This is done through The Benefit Loop®, Brighter’s cloud-based service that continuously collects, analyzes and shares data on the user's terms.

The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Remium Nordic AB +46 (0)8 – 454 32 50, CorporateFinance@remium.com, www.remium.com.

This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 09:55 CET on October 12, 2017.

About Us

Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of the most serious healthcare problems: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop™ - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and close associates, healthcare providers, research, pharmaceutical industry and society. Website: https://brighter.se/ The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Eminova Fondkommission AB +46 (0)8 – 684 211 00, info@eminova.se, www.eminova.se

Subscribe

Documents & Links